focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Miners pull UK markets lower, but Smith & Nephew rises

Fri, 30th May 2014 11:34

- Mining stocks lower on iron ore, China concerns- Fenner issues profit warning- M&A continues to boost Smith & NephewtechMARK 2,820.23 +0.39%FTSE 100 6,860.62 -0.16%FTSE 250 16,039.31 +0.53%Weakness in the mining sector dragged the UK stock market from a two-week high on Friday, despite M&A speculation boosting the share prices of Smith & Nephew and Salamander Energy.Mining stocks were trading firmly in the red as iron ore prices were headed for their sixth consecutive monthly decline, the longest losing streak on record. Meanwhile, concerns about a slowdown in China were also having an impact on stocks, as well as a profit warning from polymer products group Fenner, which makes conveyor belts for the mining industry."[Chinese] government figures indicated manufacturing growth was weakening, contradicting recent signs of improvement in the economy and providing an excuse for some selling in raw materials," said Chris Beauchamp, Market Analyst at IG.The FTSE 100 was down 0.2% at 6,861 by midday after hitting 6,871.29 on Thursday, its highest close since May 14th when it reached a new 14-year high of 6,878.49.Investors were also focusing on a batch of mixed economic data from across the globe, including an improvement in consumer confidence in the UK, weak industrial production figures and stronger-than-expected inflation in Japan, and an unexpected dip in retail sales in Germany.Miners weigh on markets, Fenner plummetsRising iron ore supplies from Australia and Brazil have prompted a 9% fall in prices this month, with the value of the commodity having now fallen every month since December. This is the longest string of monthly losses since data from The Steel Index Ltd began in November 2008, according to Bloomberg. Diversified miners Anglo American, BHP Billiton and Rio Tinto were among the worst performers on the FTSE 100, with concerns over China also dampening sentiment.In another hit to sentiment in the mining industry, Fenner issued a profit warning, causing shares to sink sharply. The group said annual profits would be 10-15% below market expectations on the back of weakness in the US coal industry, prompting analysts at Numis Securities to downgrade the stock from 'add' to 'hold'.Meanwhile, solid fuel supplier and logistics group Hargreaves Services also fell after saying results from its Production Division will be below expectations this year due to "challenging trading conditions" in coke markets and delays.Medical device maker Smith & Nephew was on the rise as bid speculation continued to drive the stock higher. While US peer Stryker was forced to publicly deny reports that it was working on a bid for the company, its boss yesterday confirmed in an interview that the company had in fact been in the early stages of considering a transaction but was not ready to make an offer. UBS this morning added the stock to its 'M&A Watch List'.GlaxoSmithKline was fluctuating between gains and losses on rumours that it has approached a number of private equity firms to gauge the interest for a range of its older drugs as it attempts to refresh its portfolio. AIM-listed oil explorer Petroceltic was trading lower after giving investors a trio of "disappointing" updates from its international drilling programme. Meanwhile, sector peer Salamander Energy surged on reports that Cia Espanola de Petroleos SAU is looking to buy to company for €700m.DIY retailer Kingfisher was continuing to fall after an underwhelming first-quarter statement yesterday as Barclays Capital cut the shares to 'equal weight' and trimmed its target price.FTSE 100 - RisersSmith & Nephew (SN.) 1,055.00p +2.53%Coca-Cola HBC AG (CDI) (CCH) 1,390.00p +1.83%Admiral Group (ADM) 1,454.00p +1.82%Hammerson (HMSO) 601.00p +1.18%Whitbread (WTB) 4,182.00p +1.06%Persimmon (PSN) 1,340.00p +1.06%Sports Direct International (SPD) 800.00p +0.88%Land Securities Group (LAND) 1,071.00p +0.85%Sage Group (SGE) 415.10p +0.80%St James's Place (STJ) 786.00p +0.77%FTSE 100 - FallersRio Tinto (RIO) 3,104.50p -2.63%Anglo American (AAL) 1,505.50p -2.56%Fresnillo (FRES) 814.00p -2.52%BHP Billiton (BLT) 1,904.00p -1.88%Morrison (Wm) Supermarkets (MRW) 199.10p -1.53%Antofagasta (ANTO) 795.50p -1.12%Royal Mail (RMG) 512.50p -1.06%G4S (GFS) 250.30p -1.03%Kingfisher (KGF) 393.10p -0.98%Barratt Developments (BDEV) 356.50p -0.94%FTSE 250 - RisersOphir Energy (OPHR) 266.50p +4.02%Micro Focus International (MCRO) 843.00p +3.56%CSR (CSR) 597.50p +3.55%Euromoney Institutional Investor (ERM) 1,178.00p +3.51%Ocado Group (OCDO) 385.20p +3.41%Supergroup (SGP) 1,145.00p +3.25%Xaar (XAR) 847.00p +3.17%Afren (AFR) 154.10p +3.15%Rank Group (RNK) 160.80p +3.08%Perform Group (PER) 272.50p +2.83%FTSE 250 - FallersFenner (FENR) 349.30p -10.37%Paragon Group Of Companies (PAG) 376.80p -3.09%Evraz (EVR) 107.00p -2.01%Drax Group (DRX) 627.00p -1.49%Vedanta Resources (VED) 1,112.00p -1.33%Smith (DS) (SMDS) 318.90p -1.33%Tate & Lyle (TATE) 693.50p -1.14%Playtech (PTEC) 665.00p -1.12%Ferrexpo (FXPO) 137.50p -1.08%TalkTalk Telecom Group (TALK) 318.50p -1.06%BC
More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.